Fig. 3From: The epigenetic immunomodulator, HBI-8000, enhances the response and reverses resistance to checkpoint inhibitorsExpression analyses of TNFα, KLRD1, CCR5, CCL2, CD137, and IRF4. Experiments and data analyses as described in Fig. 2Back to article page